Miller, Chelsea
Altoos, Basel
DeJongh, Ethan A.
Pankuch, Mark
DeJongh, Don F.
Rykalin, Victor
Ordoñez, Caesar E.
Karonis, Nicholas T.
Winans, John R.
Coutrakon, George
Welsh, James S. http://orcid.org/0000-0002-3255-6412
Funding for this research was provided by:
U.S. Army (W81XWH-10-1-0170)
US Department of Energy (DE-SC0005135)
National Cancer Institute (R44CA203499)
Article History
Received: 30 January 2019
Accepted: 12 February 2019
First Online: 19 March 2019
Compliance with ethical standards
:
: This study was funded in part by The National Cancer Institute of the National Institutes of Health contract number R44CA203499, the US Department of the Army contract number W81XWH-10-1-0170, and the US Department of Energy contract number DE-SC0005135 sponsored this work. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD, 21702–5014, is the awarding and administering acquisition office for contract number W81XWH-10-1-0170. The content in this article does not necessarily reflect the position or policy of the Government, and no official endorsement should be inferred.
: Don F. DeJongh and Victor Rykalin are co-founders of ProtonVDA, Inc., Naperville, IL, 60563, USA, and Ethan A. DeJongh is an employee of ProtonVDA, Inc. None of the other authors have relevant potential conflicts of interest. James Welsh has served in the past as an advisor to ProTom International.
: This article does not describe any work done with living animals.
: All patients from which the CT data was obtained provided informed consent for use of their anonymized images for this study.